— Know what they know.
Not Investment Advice
Also trades as: ACON (NASDAQ) · $vol 0M

ACONW NASDAQ

Aclarion, Inc.
1W: +21.7% 1M: +14.5% 3M: +10.6% YTD: +5.6% 1Y: +2.3% 3Y: -89.5%
$0.04
+0.00 (+6.10%)
 
Weekly Expected Move ±23.9%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Neutral · Power 44 · $21332 mcap · 533279 float · 2.75% daily turnover · Short 59% of daily vol
Smart Money Score
Watch 25
Insider+$0.0M
Congress
ETF Holdings
Key Statistics
Market Cap$0.0M
52W Range0.0311-0.048
Volume12,297
Avg Volume14,665
Beta-1.12
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOBrent Ness
Employees5
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2022-04-22
951 Mariners Island Boulevard
Broomfield, CA 94404
US
650-241-1741
About Aclarion, Inc.

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Recent Insider Trades

NameTypeSharesPriceDate
Neal David K P-Purchase 2,500 $3.10 2026-05-11
Wesemann William P-Purchase 1,562 $3.30 2026-05-06
Gould Gregory A 0 2025-09-02
Wesemann William A-Award 63,000 2022-12-29
Neal David K J-Other 152,128 2022-12-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms